Iovance Biotherapeutics Inc 's (IOVA) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Iovance Biotherapeutics inc   (NASDAQ: IOVA)
 



  Iovance Biotherapeutics inc Outlook

On February 27 2025 the Iovance Biotherapeutics inc provided following guidance

nnIovance Biotherapeutics Inc. Reports Robust Financial Performance and Strategic Updates for Q4 and Full Year 2024nn

On February 27, 2025, Iovance Biotherapeutics Inc. announced its financial results and corporate developments for the fourth quarter and the entirety of 2024, showcasing a strong performance relative to their previous guidance.

In the fourth quarter of 2024, the company generated a total product revenue of $73.7 million. This impressive figure contributed to an annual revenue total of $164.1 million for the fiscal year 2024, landing at the upper threshold of their previously set guidance range of $160 million to $165 million.

Demand for Amtagvi (Lifileucel) Remains Strong, With Q4 Product Revenue of $73.7M and Year-End Total of $164.1M, Surpassing FY24 Revenue Expectations



These results highlight the exceptional market response to Amtagvi (Lifileucel), reinforcing the company’s strategic initiatives and product offerings in the biotherapeutics sector. Iovance is well-positioned for continued growth as it navigates through a promising landscape for its innovative therapies.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.